WeCAN
Funding rounds backed by WeCAN.
- Funding disclosed in full
- $4.5M
- Median round
- $4.5M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| TippingPoint Biosciences Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5MSeed | BiotechUnited States |